{"id":880802,"date":"2026-10-13T12:18:09","date_gmt":"2026-10-13T12:18:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/880802\/"},"modified":"2026-10-13T12:18:09","modified_gmt":"2026-10-13T12:18:09","slug":"unitedhealth-group-unh-earnings-q3-2026","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/880802\/","title":{"rendered":"UnitedHealth Group (UNH) earnings Q3 2026"},"content":{"rendered":"<p>UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025.<\/p>\n<p>Michael Nagle | Bloomberg | Getty Images<\/p>\n<p><a href=\"https:\/\/www.cnbc.com\/quotes\/UNH\/\" rel=\"nofollow noopener\" target=\"_blank\">UnitedHealth Group<\/a> on Tuesday <a href=\"https:\/\/www.unitedhealthgroup.com\/content\/dam\/UHG\/PDF\/investors\/2026\/unh-reports-third-quarter-2026-results.pdf\" target=\"_blank\" rel=\"nofollow noopener\">posted<\/a> third-quarter earnings that blew past estimates and raised its full-year profit outlook, as the company continues to manage high medical costs and sees investments in value-based care and artificial intelligence take hold. <\/p>\n<p>The nation&#8217;s largest private insurer said it expects fiscal 2026 adjusted earnings of at least $20.50 per share, up from a previous outlook of $19.50 to $20 per share. <\/p>\n<p>The healthcare giant&#8217;s turnaround plan is gaining momentum after <a href=\"https:\/\/www.cnbc.com\/2026\/07\/16\/unitedhealth-group-unh-earnings-q2-2026.html\" rel=\"nofollow noopener\" target=\"_blank\">three consecutive strong quarters<\/a> this year. UnitedHealth is working to stabilize margins by shrinking membership, exiting unprofitable contracts and ramping up investments in artificial intelligence and value-based care, which tie doctor and facility compensation to patient health outcomes, quality of care and cost effectiveness rather than the volume of medical services provided. <\/p>\n<p>&#8220;You&#8217;ll see in the quarter that we continue to execute not only on the financial aspects of our business, but really doing them with a simpler approach and an approach that&#8217;s really focused on investing heavily in value-based care,&#8221; CFO Wayne DeVeydt said in an interview. <\/p>\n<p>Shares of the company rose about 3% in premarket trading.<\/p>\n<p>Here&#8217;s what the company reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:<\/p>\n<p>Earnings per share: $4.69 adjusted vs. $4.14 expectedRevenue: $112.69 billion vs. $111.40 billion expected<\/p>\n<p>The company posted third-quarter net income of $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the same period a year ago. Excluding items like business divestitures, restructuring and the expected reduction of reserves for unprofitable contracts, UnitedHealth earned $4.69 per share.<\/p>\n<p>Revenue fell to $112.69 billion from $113.16 billion in the prior-year quarter. The company&#8217;s insurer, UnitedHealthcare, and its Optum healthcare unit both topped analysts&#8217; operating earnings estimates for the quarter, according to StreetAccount.\u00a0<\/p>\n<p><a id=\"headline0\"\/>Managing high costs<\/p>\n<p>Notably, UnitedHealth&#8217;s medical cost ratio \u2014 a measure of total medical expenses paid relative to premiums collected \u2014 came in at 88.4% for the third quarter. Analysts were expecting a ratio of 89.9% for the quarter, according to StreetAccount. A lower ratio typically indicates that the company collected more in premiums than it paid out in benefits, resulting in higher profitability.<\/p>\n<p>Still, DeVeydt told CNBC that medical costs in the quarter &#8220;continue to be elevated versus historical norms&#8221; \u2013 an issue that has plagued insurers, particularly those operating privately run Medicare Advantage plans, for more than two years.<\/p>\n<p>&#8220;I think it&#8217;s something we should keep an eye on. I think you&#8217;ll see that our medical care ratio has improved quite a bit, but I don&#8217;t want that to be misleading in terms of [medical cost trends],&#8221; DeVeydt said.\u00a0<\/p>\n<p>He said the independent dispute resolution (IDR) process under the No Surprises Act is adding at least 100 basis points, or 1 percentage point, to total medical costs. That federal law, which took effect in 2022, aims to protect consumers from unexpected medical bills<\/p>\n<p>The IDR process allows providers and insurers to resolve disputes over out-of-network payments. DeVeydt said those changes are driving up the company&#8217;s claims costs, which can ultimately be passed on to consumers through higher premiums.<\/p>\n<p>DeVeydt added that costs for inpatient services and pharmacy, particularly costly specialty pharmacy drugs for cancer and rare diseases, remain elevated.\u00a0<\/p>\n<p>Still, he highlighted the company&#8217;s value-based care efforts, which are helping control medical costs by steering patients toward the right providers and emphasizing preventive care, DeVeydt added.\u00a0<\/p>\n<p>He said acute hospital admissions among UnitedHealth members fell 15% year over year through the third quarter, while home health admissions rose 10%, suggesting more patients are receiving care in lower-cost settings.\u00a0<\/p>\n<p>&#8220;You&#8217;re finding more members are actually getting into a lower-cost care environment, but more importantly, they&#8217;re getting into the care environment they actually want to be in,&#8221; he told CNBC. &#8220;So we think we&#8217;re really balancing both the quality and the cost.&#8221;<\/p>\n<p>UnitedHealth is also rolling out AI-powered ambient listening tools to reduce physicians&#8217; administrative burden and free up time for patient visits. Appointment scheduling done by patients rather than with the assistance of a provider increased 27% year over year, DeVeydt said.\u00a0<\/p>\n<p>He expects those initiatives to have a compounding effect on medical cost management through the fourth quarter and into 2027 as the programs expand. <\/p>\n","protected":false},"excerpt":{"rendered":"UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle&hellip;\n","protected":false},"author":2,"featured_media":880803,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[2602,244,448,28,122,8084,2601,223504,247,28170],"class_list":["post-880802","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-biotech-and-pharmaceuticals","tag-biotechnology","tag-breaking-news-business","tag-business","tag-business-news","tag-earnings","tag-health-care-industry","tag-ishares-u-s-healthcare-etf","tag-pharmaceuticals","tag-unitedhealth-group-inc"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/880802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=880802"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/880802\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/880803"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=880802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=880802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=880802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}